Cargando…

IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions

OBJECTIVE: IgG4-related hypertrophic pachymeningitis is a rare fibroinflammatory disorder that may cause localized or diffused thickening of the dura mater. Misinterpretations of the clinical and imaging findings are common. Clinical manifestations depend on the location of the inflammatory lesion a...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmaeilzadeh, Majid, Dadak, Mete, Atallah, Oday, Möhn, Nora, Skripuletz, Thomas, Hartmann, Christian, Banan, Rozbeh, Krauss, Joachim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519706/
https://www.ncbi.nlm.nih.gov/pubmed/35974231
http://dx.doi.org/10.1007/s00701-022-05340-5
_version_ 1784799459863953408
author Esmaeilzadeh, Majid
Dadak, Mete
Atallah, Oday
Möhn, Nora
Skripuletz, Thomas
Hartmann, Christian
Banan, Rozbeh
Krauss, Joachim K.
author_facet Esmaeilzadeh, Majid
Dadak, Mete
Atallah, Oday
Möhn, Nora
Skripuletz, Thomas
Hartmann, Christian
Banan, Rozbeh
Krauss, Joachim K.
author_sort Esmaeilzadeh, Majid
collection PubMed
description OBJECTIVE: IgG4-related hypertrophic pachymeningitis is a rare fibroinflammatory disorder that may cause localized or diffused thickening of the dura mater. Misinterpretations of the clinical and imaging findings are common. Clinical manifestations depend on the location of the inflammatory lesion and on compression of neural structures leading to functional deficits. A dural biopsy is commonly needed for a definitive diagnosis. Immunomodulatory therapy is considered the therapy of choice. METHODS: Four patients with IgG4-related hypertrophic pachymeningitis were identified over a 5-year period. Patient-related characteristics including age, preoperative workup, signs and symptoms of patients, and diagnostic procedures were evaluated. Furthermore, the surgical treatment and 5-year follow-up outcomes were analyzed. RESULTS: There were two adults and two adolescents (mean age 32 years; range 15 to 67 years). Two patients were male, and two were female. No history of disease was known in any of the patients. Clinical symptoms were epilepsy (n = 2), ataxia and nausea (n = 1), and facial nerve palsy (n = 1). MR imaging studies showed contrast enhancing lesions in the temporal region in two patients, and in the cerebellar region in the other two patients. Subtotal resection was performed in two instances and a biopsy via a suboccipital retrosigmoid approach was obtained in the other two patients. Histochemical and immunohistochemical investigations revealed an IgG 4 disease in all of these patients. Immunomodulatorry therapy led to clinical stability during follow-up of 5 years in all four cases. CONCLUSION: The diagnosis of IgG4-related hypertrophic pachymeningitis is challenging, but is of great relevance as treatment differs significantly from other forms of pachymeningitis and a specific therapeutic approach may avoid long-term neurological complications. Our series contributes to a better clinical characterization of this rare disease.
format Online
Article
Text
id pubmed-9519706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-95197062022-09-30 IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions Esmaeilzadeh, Majid Dadak, Mete Atallah, Oday Möhn, Nora Skripuletz, Thomas Hartmann, Christian Banan, Rozbeh Krauss, Joachim K. Acta Neurochir (Wien) Original Article - Neurosurgery general OBJECTIVE: IgG4-related hypertrophic pachymeningitis is a rare fibroinflammatory disorder that may cause localized or diffused thickening of the dura mater. Misinterpretations of the clinical and imaging findings are common. Clinical manifestations depend on the location of the inflammatory lesion and on compression of neural structures leading to functional deficits. A dural biopsy is commonly needed for a definitive diagnosis. Immunomodulatory therapy is considered the therapy of choice. METHODS: Four patients with IgG4-related hypertrophic pachymeningitis were identified over a 5-year period. Patient-related characteristics including age, preoperative workup, signs and symptoms of patients, and diagnostic procedures were evaluated. Furthermore, the surgical treatment and 5-year follow-up outcomes were analyzed. RESULTS: There were two adults and two adolescents (mean age 32 years; range 15 to 67 years). Two patients were male, and two were female. No history of disease was known in any of the patients. Clinical symptoms were epilepsy (n = 2), ataxia and nausea (n = 1), and facial nerve palsy (n = 1). MR imaging studies showed contrast enhancing lesions in the temporal region in two patients, and in the cerebellar region in the other two patients. Subtotal resection was performed in two instances and a biopsy via a suboccipital retrosigmoid approach was obtained in the other two patients. Histochemical and immunohistochemical investigations revealed an IgG 4 disease in all of these patients. Immunomodulatorry therapy led to clinical stability during follow-up of 5 years in all four cases. CONCLUSION: The diagnosis of IgG4-related hypertrophic pachymeningitis is challenging, but is of great relevance as treatment differs significantly from other forms of pachymeningitis and a specific therapeutic approach may avoid long-term neurological complications. Our series contributes to a better clinical characterization of this rare disease. Springer Vienna 2022-08-17 2022 /pmc/articles/PMC9519706/ /pubmed/35974231 http://dx.doi.org/10.1007/s00701-022-05340-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article - Neurosurgery general
Esmaeilzadeh, Majid
Dadak, Mete
Atallah, Oday
Möhn, Nora
Skripuletz, Thomas
Hartmann, Christian
Banan, Rozbeh
Krauss, Joachim K.
IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title_full IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title_fullStr IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title_full_unstemmed IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title_short IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
title_sort igg4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
topic Original Article - Neurosurgery general
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519706/
https://www.ncbi.nlm.nih.gov/pubmed/35974231
http://dx.doi.org/10.1007/s00701-022-05340-5
work_keys_str_mv AT esmaeilzadehmajid igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT dadakmete igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT atallahoday igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT mohnnora igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT skripuletzthomas igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT hartmannchristian igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT bananrozbeh igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions
AT kraussjoachimk igg4relatedhypertrophicpachymeningitiswithtumorlikeintracranialandintracerebrallesions